Rubini Jonathan Brian 4
4 · Wize Pharma, Inc. · Filed Dec 26, 2019
Insider Transaction Report
Form 4
Rubini Jonathan Brian
10% Owner
Transactions
- Purchase
Common Stock
2019-12-20$0.27/sh+2,037,037$550,000→ 2,455,739 total - Purchase
Warrants
2019-12-20+4,074,047→ 4,074,047 totalExercise: $0.27Exp: 2024-12-19→ Common Stock (4,074,047 underlying)
Footnotes (1)
- [F1]Exercisable five days following the public announcement of positive clinical data results for LO2A